Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Calancardin B may help reduce inflammation in immune cells.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Eating Citrullus colocynthis can cause severe intestinal bleeding and damage.

Upadacitinib effectively treats pyoderma gangrenosum.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Early diagnosis and treatment are crucial for skin emergencies and drug reactions.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Centipeda minima and brevilin A protect skin cells from damage and aging.

Clinical features of hyperandrogenism do not predict the success of conventional acne treatment in women.

2Br-Crebanine and Stephanine reduce inflammation and pain effectively.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

Straightening and dyeing damage hair structure.

Alarmin cytokines are key in controlling skin immunity and inflammation.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Retinol may affect immune responses in people with frequent skin boils.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The hydrogel dressing effectively treats chronic wounds by regulating inflammation and improving healing.